Necrostatin-1 blocks both RIPK1 and IDO: Consequences for the study of cell death in experimental disease models

Cell Death and Differentiation

Volumn 20, Issue 2, 2013, Pages 185-187

  Vandenabeele, P ^a   Grootjans, S ^a   Callewaert, N ^a,b   Takahashi, N ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR NEC1; PHOSPHOTRANSFERASE RIPK1; UNCLASSIFIED DRUG;

CELL DEATH; CHEMICAL STRUCTURE; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HUMAN; INFLAMMATION; NECROPTOSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; HUMANS; IMIDAZOLES; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INDOLES; INFLAMMATION; MICE; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 84872343093     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2012.151     Document Type: Review

References (19)

1. Degterev A, Maki JL, Yuan J. Cell Death Differ 2013; 20: 366.
2. Takahashi N et al. Cell Death Dis 2012; 3: e437.
3. Degterev A et al. Nat Chem Biol 2008; 4: 313-321.
4. Degterev A et al. Nat Chem Biol 2005; 1: 112-119.
5. Linkermann A et al. Kidney Int 2012; 81: 751-761.
6. Smith CC et al. Cardiovasc Drugs Ther 2007; 21: 227-233.
7. Trichonas G et al. Proc Natl Acad Sci USA 2010; 107: 21695-21700.
8. Duprez L et al. Immunity 2011; 35: 908-918.
9. Muller AJ et al. Nat Med 2005; 11: 312-319.
10. Prendergast GC, Metz R, Muller AJ. Am J Pathol 2010; 176: 2082-2087.
11. Institute HLMCCaR A Phase 1 Study of 1-Methyl-D-tryptophan in Patients with Advanced Malignancies, 2012.
12. Feoktistova M et al. Mol Cell 2011; 43: 449-463.
13. Tenev T et al. Mol Cell 2011; 43: 432-448.
14. Kaiser WJ et al. Nature 2011; 471: 368-372.
15. Oberst A et al. Nature 2011; 471: 363-367.
16. Gunther C et al. Nature 2011; 477: 335-339.
17. Kovalenko A et al. J Exp Med 2009; 206: 2161-2177.
18. Linkermann A et al. Mol Med 2012; 18: 577-586.
19. McNeal SI et al. Shock 2011; 35: 499-505.